—

Fagron NV(FAGR.BR)— 同类公司组

数据截至2026-11-16 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Fagron NV的Closelook综合评分为54/100,在同类公司组内排名第7位(共7家)——组内评分最高的是Laboratorios Farmaceuticos ROVI(63/100)。

名称综合动量质量估值信号距52周高点
FAGR.BR Fagron NV54655556info4%
ROVI.MC Laboratorios Farmaceuticos ROVI63627442info18.3%
LNTH Lantheus Holdings Inc59727353ok9.1%
IRWD Ironwood Pharmaceuticals Inc58757782info16.1%
KNSA Kiniksa Pharmaceuticals Ltd58936117ok5.1%
GALDY GALDERMA GROUP AG56715921ok5.1%
ALM.MC Almirall S.A.55444565info22.9%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-11-16

Quick answers

Fagron NV在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Ironwood Pharmaceuticals Inc (IRWD)、Kiniksa Pharmaceuticals Ltd (KNSA)、GALDERMA GROUP AG (GALDY)、Almirall S.A. (ALM.MC)。

FAGR.BR相对同类公司的评分如何?

Fagron NV的综合评分为54/100,组内排名第7位(共7家),截至2026-11-16;组内最高综合评分为Laboratorios Farmaceuticos ROVI(63/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.